This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2dn9
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Solution structure of J-domain from the DnaJ homolog, human Tid1 protein== | ==Solution structure of J-domain from the DnaJ homolog, human Tid1 protein== | ||
| - | <StructureSection load='2dn9' size='340' side='right'caption='[[2dn9 | + | <StructureSection load='2dn9' size='340' side='right'caption='[[2dn9]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2dn9]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[2dn9]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2DN9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2DN9 FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2dn9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2dn9 OCA], [https://pdbe.org/2dn9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2dn9 RCSB], [https://www.ebi.ac.uk/pdbsum/2dn9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2dn9 ProSAT], [https://www.topsan.org/Proteins/RSGI/2dn9 TOPSAN]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2dn9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2dn9 OCA], [https://pdbe.org/2dn9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2dn9 RCSB], [https://www.ebi.ac.uk/pdbsum/2dn9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2dn9 ProSAT], [https://www.topsan.org/Proteins/RSGI/2dn9 TOPSAN]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/DNJA3_HUMAN DNJA3_HUMAN] Modulates apoptotic signal transduction or effector structures within the mitochondrial matrix. Affect cytochrome C release from the mitochondria and caspase 3 activation, but not caspase 8 activation. Isoform 1 increases apoptosis triggered by both TNF and the DNA-damaging agent mytomycin C; in sharp contrast, isoform 2 suppresses apoptosis. Can modulate IFN-gamma-mediated transcriptional activity. Isoform 2 may play a role in neuromuscular junction development as an effector of the MUSK signaling pathway. | |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
| Line 24: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Inoue | + | [[Category: Inoue M]] |
| - | [[Category: Kigawa | + | [[Category: Kigawa T]] |
| - | [[Category: Kobayashi | + | [[Category: Kobayashi N]] |
| - | [[Category: Koshiba | + | [[Category: Koshiba S]] |
| - | + | [[Category: Tomizawa T]] | |
| - | [[Category: Tomizawa | + | [[Category: Yokoyama S]] |
| - | [[Category: Yokoyama | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Solution structure of J-domain from the DnaJ homolog, human Tid1 protein
| |||||||||||

